Gagné, Myriam http://orcid.org/0000-0002-0559-5731
Lauzier, Sophie
Babineau-Therrien, Justine
Hamel, Christine
Penney, Sara-Edith
Bourbeau, Jean
Moisan, Jocelyne
Boulet, Louis-Philippe
Clinical trials referenced in this document:
Documents that mention this clinical trial
COPD-Specific Self-Management Support Provided by Trained Educators in Everyday Practice is Associated with Improved Quality of Life, Health-Directed Behaviors, and Skill and Technique Acquisition: A Convergent Embedded Mixed-Methods Study
https://doi.org/10.1007/s40271-019-00386-7
Article History
First Online: 10 September 2019
Compliance with Ethical Standards
:
: The Laval University Knowledge Translation, Education and Prevention Chair in Respiratory and Cardiovascular Health funded the study. For the development and deployment of the training, the Université Laval Knowledge Translation, Education and Prevention Chair in Respiratory and Cardiovascular Health received funding from the GlaxoSmithKline Medical Education Support Program (the program funds were not used in connection with the research). As part of her doctoral studies, Myriam Gagné received a scholarship from the Fonds de recherche du Québec – Santé to conduct the present study.
: The authors alone are responsible for the content and writing of this paper. The Université Laval Knowledge Translation, Education and Prevention Chair in Respiratory and Cardiovascular Health is supported by unrestricted grants from AstraZeneca. The Chair has received funding from GlaxoSmithKline for the development and deployment of the educational component. The program funds were not used in connection with the research. The funding body had no role in the study design, collection, analysis, or interpretation of the data. The publication of our study results will not be contingent on our sponsor’s approval or censorship of the manuscript. The Québec Respiratory Health Education Network is supported by unrestricted grants from AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, and Novartis. Myriam Gagné, Sophie Lauzier, Justine Babineau-Therrien, Christine Hamel, Sara-Edith Penney, Jean Bourbeau, and Jocelyne Moisan have no conflicts of interest that are directly relevant to the content of this article. Louis-Philippe Boulet declares the following potential conflicts of interest—last 3 years: <i>Research grants for participation to multicenter studies:</i> AstraZeneca, Boston Scientific, GlaxoSmithKline, Hoffman La Roche, Novartis, Ono Pharma, Sanofi, Takeda. <i>Support for research projects introduced by the investigator:</i> AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck, Takeda. <i>Consulting and advisory boards:</i> Astra Zeneca, Novartis, Methapharm. <i>Royalties:</i> Co-author of “Up-To-Date” (occupational asthma). <i>Non-profit grants for production of educational materials:</i> AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck Frosst, Novartis. <i>Conference fees:</i> AstraZeneca, GlaxoSmithKline, Merck, Novartis. <i>Support for participation in conferences and meetings:</i> Novartis, Takeda.
: The trial has been approved by the Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval Ethics Committee (Approval number: MP-10-2016-2591).
: Informed consent was obtained from all participants included in the study.